Cargando…

Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality

BACKGROUND AND AIMS: Hypertension (HTN) is a common comorbidity in non-alcoholic fatty liver disease (NAFLD) affecting up to 40% of individuals. However, the impact of HTN and its control on outcomes in NAFLD remains unclear. Therefore, we aimed to examine the impact of HTN on survival outcomes in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Cheng Han, Wong, Zhen Yu, Chew, Nicholas W. S., Chan, Kai En, Xiao, Jieling, Sayed, Nilofer, Lim, Wen Hui, Tan, Darren Jun Hao, Loke, Ryan Wai Keong, Tay, Phoebe Wen Lin, Yong, Jie Ning, Kong, Gywneth, Huang, Daniel Q., Wang, Jiong-Wei, Chan, Mark, Dalakoti, Mayank, Tamaki, Nobuharu, Noureddin, Mazen, Siddiqui, Mohammad Shadab, Sanyal, Arun J., Muthiah, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393330/ https://www.ncbi.nlm.nih.gov/pubmed/36003916 http://dx.doi.org/10.3389/fcvm.2022.942753

Ejemplares similares

Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia
por: Xiao, Jieling, et al.
Publicado: (2022)

Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals
por: Lim, Wen Hui, et al.
Publicado: (2022)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
por: Noureddin, Mazen, et al.
Publicado: (2019)

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
por: Fu, Clarissa Elysia, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
por: Tang, Ansel Shao Pin, et al.
Publicado: (2022)

The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis
por: Chin, Yip Han, et al.
Publicado: (2022)

DEXA Scan Body Fat Mass Distribution in Obese and Non-Obese Individuals and Risk of NAFLD—Analysis of 10,865 Individuals
por: Tan, Caitlyn, et al.
Publicado: (2022)

868: PREVENTING HEPATCELLULAR CARCINOMA WITH TENOFOVIR VS ENTECAVIR: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF PROPENSITY SCORE MATCHED STUDIES
por: Tan, Darren J., et al.
Publicado: (2022)

Can glucose‐lowering medications improve outcomes in non‐diabetic heart failure patients? A Bayesian network meta‐analysis
por: Yeong, Trevor, et al.
Publicado: (2022)

Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
por: Tan, Darren Jun Hao, et al.
Publicado: (2022)

Predictive and Prognostic Roles of Gut Microbial Variation in Liver Transplant
por: Wong, Hon Jen, et al.
Publicado: (2022)

A qualitative systematic review of anonymous/unspecified living kidney and liver donors’ perspectives
por: Lim, Wen Hui, et al.
Publicado: (2022)

Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals
por: Ng, Cheng Han, et al.
Publicado: (2023)

Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals
por: Nah, Benjamin Kai Yi, et al.
Publicado: (2022)

The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
por: Ng, Cheng Han, et al.
Publicado: (2022)

Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis
por: Tan, Darren Jun Hao, et al.
Publicado: (2022)

Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials
por: Tan, Darren Jun Hao, et al.
Publicado: (2023)

Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
por: Xiao, Jieling, et al.
Publicado: (2021)

Healthier SG – throwing down the gauntlet for specialists to integrate
por: Dalakoti, Mayank, et al.
Publicado: (2023)

Effect of Surgical Mask use on Peak Physical Performance During Exercise Treadmill Testing-A Real World, Crossover Study
por: Dalakoti, Mayank, et al.
Publicado: (2022)

An Epidemiological Meta-Analysis on the Worldwide Prevalence, Resistance, and Outcomes of Spontaneous Bacterial Peritonitis in Cirrhosis
por: Tay, Phoebe Wen Lin, et al.
Publicado: (2021)

General Public’s knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study population
por: Anand, Vickram Vijay, et al.
Publicado: (2023)

Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
por: Noureddin, Mazen, et al.
Publicado: (2018)

Global incidence and prevalence of nonalcoholic fatty liver disease
por: Teng, Margaret LP, et al.
Publicado: (2023)

Hepatitis Delta: Epidemiology, Diagnosis and Management 36 Years After Discovery
por: Noureddin, Mazen, et al.
Publicado: (2013)

Current and Potential Therapies Targeting Inflammation in NASH
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?
por: Noureddin, Nabil, et al.
Publicado: (2020)

A network meta-analysis of 12,116 individuals from randomized controlled trials in the treatment of depression after acute coronary syndrome
por: Lim, Grace En Hui, et al.
Publicado: (2022)

STELLAR 3 and STELLAR 4: Lessons from the fall of Icarus
por: Rinella, Mary E., et al.
Publicado: (2020)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
por: Eskridge, Wayne, et al.
Publicado: (2023)

Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment
por: Alkhouri, Naim, et al.
Publicado: (2019)

Review article: the impact of liver‐directed therapies on the atherogenic risk profile in non‐alcoholic steatohepatitis
por: Connelly, Margery A., et al.
Publicado: (2020)

Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
por: Zelber-Sagi, Shira, et al.
Publicado: (2021)

Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know
por: Barritt, A. Sidney, et al.
Publicado: (2022)

Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019
por: Chong, Bryan, et al.
Publicado: (2023)

Evaluation of liver stiffness measurement–based scores in liver transplantation recipients
por: Arshad, Tamoore, et al.
Publicado: (2023)

Quality of life and related factors of nursing home residents in Singapore
por: Wang, Pei, et al.
Publicado: (2016)

Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge
por: Steggerda, Justin A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_80hntmuaeosvnb301mf6eksd2i